These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 26576437)

  • 1. Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus.
    Hashemian SJ; Kouhnavard M; Nasli-Esfahani E
    J Diabetes Res; 2015; 2015():675103. PubMed ID: 26576437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
    Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
    Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus.
    Domouky AM; Hegab AS; Al-Shahat A; Raafat N
    Int J Biochem Cell Biol; 2017 Jun; 87():77-85. PubMed ID: 28385600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell-based therapy for the treatment of type 1 diabetes mellitus.
    Mabed M; Shahin M
    Curr Stem Cell Res Ther; 2012 May; 7(3):179-90. PubMed ID: 22023626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-stimulated insulin secretion of various mesenchymal stem cells after insulin-producing cell differentiation.
    Kim SJ; Choi YS; Ko ES; Lim SM; Lee CW; Kim DI
    J Biosci Bioeng; 2012 Jun; 113(6):771-7. PubMed ID: 22425523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells.
    Sharma A; Rani R
    Stem Cell Res Ther; 2017 Jul; 8(1):167. PubMed ID: 28701182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose tissue-derived mesenchymal stromal cells efficiently differentiate into insulin-producing cells in pancreatic islet microenvironment both in vitro and in vivo.
    Karaoz E; Okcu A; Ünal ZS; Subasi C; Saglam O; Duruksu G
    Cytotherapy; 2013 May; 15(5):557-70. PubMed ID: 23388582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of stem cells from umbilical cord blood as therapy for type I diabetes.
    Stiner R; Alexander M; Liu G; Liao W; Liu Y; Yu J; Pone EJ; Zhao W; Lakey JRT
    Cell Tissue Res; 2019 Nov; 378(2):155-162. PubMed ID: 31209568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Progress and Challenges.
    Ghoneim MA; Refaie AF; Elbassiouny BL; Gabr MM; Zakaria MM
    Stem Cell Rev Rep; 2020 Dec; 16(6):1156-1172. PubMed ID: 32880857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human umbilical cord-derived mesenchymal stem cells can secrete insulin in vitro and in vivo.
    Boroujeni ZN; Aleyasin A
    Biotechnol Appl Biochem; 2014; 61(2):82-92. PubMed ID: 23725211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mesenchymal stem cells and type 1 diabetes treatment].
    Boháčová P; Holáň V
    Vnitr Lek; 2018; 64(7-8):725-728. PubMed ID: 30441979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of PDX1 gene-modified human umbilical cord mesenchymal stem cells into insulin-producing cells in vitro.
    He D; Wang J; Gao Y; Zhang Y
    Int J Mol Med; 2011 Dec; 28(6):1019-24. PubMed ID: 21837359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells in the treatment of type 1 diabetes mellitus.
    Katuchova J; Harvanova D; Spakova T; Kalanin R; Farkas D; Durny P; Rosocha J; Radonak J; Petrovic D; Siniscalco D; Qi M; Novak M; Kruzliak P
    Endocr Pathol; 2015 May; 26(2):95-103. PubMed ID: 25762503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cell therapy for diabetes through paracrine mechanisms.
    Xu YX; Chen L; Wang R; Hou WK; Lin P; Sun L; Sun Y; Dong QY
    Med Hypotheses; 2008 Sep; 71(3):390-3. PubMed ID: 18538944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obestatin can potentially differentiate Wharton's jelly mesenchymal stem cells into insulin-producing cells.
    El-Asfar RK; Kamal MM; Abd El-Razek RS; El-Demerdash E; El-Mesallamy HO
    Cell Tissue Res; 2018 Apr; 372(1):91-98. PubMed ID: 29159483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
    Yaochite JN; de Lima KW; Caliari-Oliveira C; Palma PV; Couri CE; Simões BP; Covas DT; Voltarelli JC; Oliveira MC; Donadi EA; Malmegrim KC
    Stem Cell Res Ther; 2016 Jan; 7():14. PubMed ID: 26781648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes.
    Mohammadi Ayenehdeh J; Niknam B; Rasouli S; Hashemi SM; Rahavi H; Rezaei N; Soleimani M; Liaeiha A; Niknam MH; Tajik N
    Immunol Lett; 2017 Aug; 188():21-31. PubMed ID: 28506774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of mesenchymal stem cells to insulin-producing cells and their impact on type 1 diabetic rats.
    Neshati Z; Matin MM; Bahrami AR; Moghimi A
    J Physiol Biochem; 2010 Jun; 66(2):181-7. PubMed ID: 20422338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Infusion of Human Adipose Tissue-Derived Mesenchymal Stem Cells to Treat Type 1 Diabetic Mellitus in Mice: An Evaluation of Grafted Cell Doses.
    Dang LT; Bui AN; Le-Thanh Nguyen C; Truong NC; Bui AT; Kim NP; Truong KD; Van Pham P
    Adv Exp Med Biol; 2018; 1083():145-156. PubMed ID: 29423674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Immunological Considerations.
    Refaie AF; Elbassiouny BL; Kloc M; Sabek OM; Khater SM; Ismail AM; Mohamed RH; Ghoneim MA
    Front Immunol; 2021; 12():690623. PubMed ID: 34248981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.